MOASC Purchasing Network, Inc

Oncology Drug Shortage Rising

 

Over the past year, many cancer centers across the country have experienced a significant growing shortage in their chemotherapy supplies. Although such drug shortages have occurred in the past, this deficit represents 20 chemotherapy drugs, almost twice the number of previous scarcities. Additionally, many of the chemotherapy drugs in short supply this year are widely used generics, which has exacerbated the shortage's impact among cancer care providers.

 

In response to growing chemotherapy drug shortages nationwide, many of which are reaching crisis proportions, the American Society of Clinical Oncology (ASCO) recently announced their support of the Preserving Access to Life-Saving Medications Act. This legislation aims to address chemotherapy drug shortages caused by regulatory and manufacturing issues and would expand the US Food and Drug Administration's (FDA's) authority to require manufacturers to notify the FDA of the nature and expected duration of shortages. Currently, pharmaceutical manufacturers are not legally required to cite reasons for delays or halts in production to the public or the FDA, nor are they required to provide details as to how long drug shortages are expected to last. This law would change that. 

  

Read More

 

Scientists Discover First Breast Cancer 'Oncogene' For Five Years 

 

Cancer Research UK scientists have pinpointed a key cancer-causing gene that, when overactive, triggers a particularly aggressive type of breast cancer to develop.

This is the first time in over five years that scientists have discovered a new breast cancer 'oncogene' - cancer-causing genes that when overactive upset the normal checks and balances that control when and how often a cell divides.

The researchers, based at Cancer Research UK's Cambridge Research Institute at the University of Cambridge and at the British Columbia Cancer Agency in Vancouver, Canada, believe testing patients tumours to see if the gene - called 'ZNF703' - is overactive could help identify patients with more aggressive tumours, so their treatment can be tailored accordingly.

Read More

Cancer specialists urged to be frank with dying patients
Associated Press

 

Patients don't want to hear that they're dying, and doctors don't want to tell them. But new guidance for cancer specialists says they should be up front with patients and far sooner.

 

The American Society of Clinical Oncology says patients often aren't told about options like comfort care, or even that their chemo has become futile, until the bitter end.

 

To help families broach the topic, too, the group developed an easy-to-read booklet about choices, from standard care to symptom relief, and what to ask to maximize remaining time.


 MPN PriceMatchFinal
Price Matching
When practices submit price matches all MPN members benefit! Thanks to the watchful eyes of our members, MPN participating practices are driving down drug costs. 

 

Plus the submitting practice will receive a $100 grant for price matches approved through Oncology Supply.
 
Contact Melissa Welch to submit a price match request.

Training Opportunities

Helpful Links
Contact Us
Melissa Welch
MOASC Purchasing Network
6921 Shoreview Dr
McKinney. TX 75070
877-787-0594 melissa@moascpurchasing.com
Phone: (877) 787-0594 · Fax: (972) 692-8331 · email: administrator@moascpurchasing.com
Copyright © 2011 MOASC Purchasing Network, Inc.